Wikidata entity: Q422232
C₂₀H₂₂N₈O₅ (P274)
Quantities
| P4250 | defined daily dose | 2.5 |
| P2067 | mass | 454.171 |
| P3780 | active ingredient in | ... | Q29006226 (Nordimet) | Nordimet |
| P3780 | active ingredient in | ... | Q47521949 (Otrexup) | Otrexup |
| P3780 | active ingredient in | ... | Q47522087 (Rheumatrex) | Rheumatrex |
| P3780 | active ingredient in | ... | Q47522224 (Trexall) | Trexall |
| P3780 | active ingredient in | ... | Q47522318 (Xatmep) | Xatmep |
| P3780 | active ingredient in | ... | Q48828089 (Rasuvo) | Rasuvo |
| P233 | canonical SMILES | String | CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O | ??? |
| P373 | Commons category | String | Methotrexate | ??? |
| P703 | found in taxon | ... | Q948827 (Asimina triloba) | Asimina triloba |
| P703 | found in taxon | ... | Q1809933 (Dolichousnea longissima) | Dolichousnea longissima |
| P703 | found in taxon | ... | Q10648042 (Quambalaria cyanescens) | Quambalaria cyanescens |
| P703 | found in taxon | ... | Q18601090 (Gambierdiscus) | Gambierdiscus |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q1477 (ulcerative colitis) | ulcerative colitis |
| P2175 | medical condition treated | ... | Q29496 (leukemia) | leukemia |
| P2175 | medical condition treated | ... | Q52849 (ankylosing spondylitis) | ankylosing spondylitis |
| P2175 | medical condition treated | ... | Q128581 (breast cancer) | breast cancer |
| P2175 | medical condition treated | ... | Q136312 (central nervous system lymphoma) | central nervous system lymphoma |
| P2175 | medical condition treated | ... | Q170990 (arthritis) | arthritis |
| P2175 | medical condition treated | ... | Q187255 (rheumatoid arthritis) | rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q189588 (stomach cancer) | stomach cancer |
| P2175 | medical condition treated | ... | Q207087 (ectopic pregnancy) | ectopic pregnancy |
| P2175 | medical condition treated | ... | Q208414 (lymphoma) | lymphoma |
| P2175 | medical condition treated | ... | Q264118 (acute myeloid leukemia) | acute myeloid leukemia |
| P2175 | medical condition treated | ... | Q324464 (testicular cancer) | testicular cancer |
| P2175 | medical condition treated | ... | Q280027 (uveitis) | uveitis |
| P2175 | medical condition treated | ... | Q372701 (esophageal cancer) | esophageal cancer |
| P2175 | medical condition treated | ... | Q549534 (osteosarcoma) | osteosarcoma |
| P2175 | medical condition treated | ... | Q612108 (acute promyelocytic leukemia) | acute promyelocytic leukemia |
| P2175 | medical condition treated | ... | Q707816 (giant cell arteritis) | giant cell arteritis |
| P2175 | medical condition treated | ... | Q861224 (juvenile rheumatoid arthritis) | juvenile rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q980926 (polymyositis) | polymyositis |
| P2175 | medical condition treated | ... | Q1004647 (bullous pemphigoid) | bullous pemphigoid |
| P2175 | medical condition treated | ... | Q1138590 (non-Hodgkin lymphoma) | non-Hodgkin lymphoma |
| P2175 | medical condition treated | ... | Q1161568 (granulomatosis with polyangiitis) | granulomatosis with polyangiitis |
| P2175 | medical condition treated | ... | Q1274464 (polyarthritis) | polyarthritis |
| P2175 | medical condition treated | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P2175 | medical condition treated | ... | Q1783924 (head and neck cancer) | head and neck cancer |
| P2175 | medical condition treated | ... | Q2626074 (diffuse large B-cell lymphoma) | diffuse large B-cell lymphoma |
| P2175 | medical condition treated | ... | Q1891209 (mycosis fungoides) | mycosis fungoides |
| P2175 | medical condition treated | ... | Q4676432 (acropustulosis) | acropustulosis |
| P2175 | medical condition treated | ... | Q4833719 (B-cell lymphoma) | B-cell lymphoma |
| P2175 | medical condition treated | ... | Q7239590 (precursor T-cell lymphoblastic leukemia) | precursor T-cell lymphoblastic leukemia |
| P2175 | medical condition treated | ... | Q7667896 (T-cell lymphoma) | T-cell lymphoma |
| P2175 | medical condition treated | ... | Q7845637 (trophoblastic neoplasm) | trophoblastic neoplasm |
| P2175 | medical condition treated | ... | Q17148432 (systemic-onset juvenile idiopathic arthritis) | systemic-onset juvenile idiopathic arthritis |
| P2175 | medical condition treated | ... | Q18556020 (lung benign neoplasm) | lung benign neoplasm |
| P2175 | medical condition treated | ... | Q18975788 (spindle cell sarcoma) | spindle cell sarcoma |
| P2175 | medical condition treated | ... | Q55781316 (osteoarthritis susceptibility 1) | osteoarthritis susceptibility 1 |
| P2175 | medical condition treated | ... | Q55789426 (precursor T-cell acute lymphoblastic leukemia) | precursor T-cell acute lymphoblastic leukemia |
| P2175 | medical condition treated | ... | Q56014449 (precursor B-cell acute lymphoblastic leukemia) | precursor B-cell acute lymphoblastic leukemia |
| P2175 | medical condition treated | ... | Q56014469 (bone sarcoma) | bone sarcoma |
| P361 | part of | ... | Q14819383 (response to methotrexate) | response to methotrexate |
| P361 | part of | ... | Q21121083 (methotrexate transmembrane transporter activity) | methotrexate transmembrane transporter activity |
| P361 | part of | ... | Q21173728 (cellular response to methotrexate) | cellular response to methotrexate |
| P129 | physically interacts with | ... | Q21121086 (solute carrier family 46 member 1) | solute carrier family 46 member 1 |
| P129 | physically interacts with | ... | Q21126218 (solute carrier family 19 member 1) | solute carrier family 19 member 1 |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123619 (US pregnancy category X) | US pregnancy category X |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q432083 (intramuscular injection) | intramuscular injection |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P636 | route of administration | ... | Q1320251 (intrathecal administration) | intrathecal administration |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q341500 (acitretin) | acitretin |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q415843 (sulfamethoxazole) | sulfamethoxazole |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420387 (foscarnet) | foscarnet |
| P769 | significant drug interaction | ... | Q422665 (trimethoprim) | trimethoprim |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P3364 | stereoisomer of | ... | Q27292170 ((R)-methotrexate) | (R)-methotrexate |
| P279 | subclass of | ... | Q27165469 (Amethopterin) | Amethopterin |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q127060 (folic acid) | folic acid |
| P2868 | subject has role | ... | Q249619 (immunosuppressive drug) | immunosuppressive drug |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2868 | subject has role | ... | Q810254 (disease-modifying antirheumatic drug) | disease-modifying antirheumatic drug |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q1809112 (dermatologic drug) | dermatologic drug |
| P2868 | subject has role | ... | Q50415114 (Abortifacient Agents, Nonsteroidal) | Abortifacient Agents, Nonsteroidal |
| P2868 | subject has role | ... | Q50429867 (antineoplastic antimetabolite) | antineoplastic antimetabolite |
| P2868 | subject has role | ... | Q50573407 (folic acid antagonists) | folic acid antagonists |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | methotrexate | ??? |
| P267 | ATC code | L01BA01 |
| P267 | ATC code | L04AX03 |
| P7524 | CA PROP 65 ID | methotrexate |
| P11931 | CAMEO Chemicals ID | 20602 |
| P231 | CAS Registry Number | 59-05-2 |
| P683 | ChEBI ID | 44185 |
| P592 | ChEMBL ID | CHEMBL34259 |
| P661 | ChemSpider ID | 112728 |
| P3073 | CosIng number | 95795 |
| P9272 | DeCS ID | 28169 |
| P715 | DrugBank ID | DB00563 |
| P11198 | DrugCentral ID | 1751 |
| P8494 | DSSTOX compound identifier | DTXCID80822 |
| P3117 | DSSTox substance ID | DTXSID4020822 |
| P232 | EC number | 200-413-8 |
| P2566 | ECHA Substance Infocard ID | 100.000.376 |
| P9635 | electronic Essential Medicines List medicine ID | 99 |
| P1417 | Encyclopædia Britannica Online ID | science/methotrexate |
| P646 | Freebase ID | /m/01q2jc |
| P227 | GND ID | 4038985-6 |
| P12385 | Gran Enciclopèdia Catalana ID | metotrexat |
| P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0123343 |
| P595 | Guide to Pharmacology Ligand ID | 4815 |
| P595 | Guide to Pharmacology Ligand ID | 4674 |
| P2062 | HSDB ID | 3123 |
| P2057 | Human Metabolome Database ID | HMDB0014703 |
| P4168 | IEDB Epitope ID | 230085 |
| P234 | InChI | InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1 |
| P235 | InChIKey | FBOZXECLQNJBKD-ZDUSSCGKSA-N |
| P665 | KEGG ID | D00142 |
| P244 | Library of Congress authority ID | sh85084418 |
| P6689 | MassBank accession ID | MSBNK-Athens_Univ-AU273001 |
| P6689 | MassBank accession ID | MSBNK-Athens_Univ-AU273002 |
| P6689 | MassBank accession ID | MSBNK-Athens_Univ-AU273003 |
| P6689 | MassBank accession ID | MSBNK-Athens_Univ-AU273004 |
| P6689 | MassBank accession ID | MSBNK-Athens_Univ-AU273005 |
| P6689 | MassBank accession ID | MSBNK-Athens_Univ-AU273006 |
| P10245 | MedlinePlus drug identifier | a682018 |
| P10245 | MedlinePlus drug identifier | a682019 |
| P6694 | MeSH concept ID | M0013595 |
| P486 | MeSH descriptor ID | D008727 |
| P672 | MeSH tree code | D03.633.100.733.631.192.500 |
| P6366 | Microsoft Academic ID (discontinued) | 2781059491 |
| P6366 | Microsoft Academic ID (discontinued) | 2908869771 |
| P2004 | NALT ID | 10468 |
| P3640 | National Drug Code | 61703-408 |
| P3640 | National Drug Code | 61703-350 |
| P8189 | National Library of Israel J9U ID | 987007529313305171 |
| P2115 | NDF-RT ID | N0000147916 |
| P2840 | NSC number | 740 |
| P10283 | OpenAlex ID | C2781059491 |
| P10283 | OpenAlex ID | C2909950847 |
| P12594 | OSHA Occupational Chemical Database ID | 874 |
| P4235 | PatientsLikeMe treatment ID | methotrexate |
| P3636 | PDB ligand ID | MTX |
| P638 | PDB structure ID | 1D1G |
| P638 | PDB structure ID | 3HJ3 |
| P638 | PDB structure ID | 1DRA |
| P638 | PDB structure ID | 2QK8 |
| P638 | PDB structure ID | 1U70 |
| P638 | PDB structure ID | 3QXV |
| P638 | PDB structure ID | 1RB3 |
| P638 | PDB structure ID | 1DF7 |
| P638 | PDB structure ID | 1MXF |
| P638 | PDB structure ID | 4DFR |
| P638 | PDB structure ID | 1DLS |
| P638 | PDB structure ID | 2C7V |
| P638 | PDB structure ID | 4P66 |
| P638 | PDB structure ID | 3EIG |
| P638 | PDB structure ID | 3QXT |
| P638 | PDB structure ID | 1U72 |
| P638 | PDB structure ID | 4KN0 |
| P638 | PDB structure ID | 3IA4 |
| P638 | PDB structure ID | 4P68 |
| P638 | PDB structure ID | 5HI6 |
| P638 | PDB structure ID | 1DDR |
| P638 | PDB structure ID | 1DRE |
| P638 | PDB structure ID | 4KY8 |
| P638 | PDB structure ID | 1RA3 |
| P638 | PDB structure ID | 4Q0D |
| P638 | PDB structure ID | 3DAU |
| P638 | PDB structure ID | 1DDS |
| P638 | PDB structure ID | 1AO8 |
| P638 | PDB structure ID | 1AXW |
| P638 | PDB structure ID | 1RH3 |
| P638 | PDB structure ID | 1E7W |
| P638 | PDB structure ID | 3DAT |
| P638 | PDB structure ID | 1RG7 |
| P638 | PDB structure ID | 1RX3 |
| P638 | PDB structure ID | 4L8W |
| P638 | PDB structure ID | 4L6H |
| P638 | PDB structure ID | 1TDR |
| P638 | PDB structure ID | 4QI9 |
| P638 | PDB structure ID | 1DHJ |
| P638 | PDB structure ID | 2OIP |
| P638 | PDB structure ID | 3DFR |
| P638 | PDB structure ID | 1DRB |
| P638 | PDB structure ID | 3IX9 |
| P638 | PDB structure ID | 2DRC |
| P638 | PDB structure ID | 4L8F |
| P638 | PDB structure ID | 5J7W |
| P638 | PDB structure ID | 4GH8 |
| P638 | PDB structure ID | 1P33 |
| P638 | PDB structure ID | 3CD2 |
| P638 | PDB structure ID | 3DRC |
| P638 | PDB structure ID | 3TQ9 |
| P638 | PDB structure ID | 1DHI |
| P638 | PDB structure ID | 3CL9 |
| P11199 | Probes And Drugs ID | PD002823 |
| P662 | PubChem CID | 126941 |
| P3417 | Quora topic ID | Methotrexate |
| P1579 | Reaxys registry number | 70669 |
| P3345 | RxNorm CUI | 6851 |
| P5076 | Römpp online ID | RD-13-01707 |
| P4964 | SPLASH | splash10-0fai-6900000000-25b0e287457fb3845ef4 |
| P5082 | Store medisinske leksikon ID | metotreksat |
| P2877 | SureChEMBL ID | 3711 |
| P4527 | UK Parliament thesaurus ID | 11575 |
| P2892 | UMLS CUI | C0025677 |
| P11089 | UniChem compound ID | 647984 |
| P652 | UNII | YL5FZ2Y5U1 |
| P11143 | WikiProjectMed ID | Methotrexate |
| P3471 | WikiSkripta article ID | 7572 |
| P8814 | WordNet 3.1 Synset ID | 03761241-n |
| P13591 | Yale LUX ID | concept/0ec2699c-0443-4233-9d12-52a8c8cc355c |
| P679 | ZVG number | 490067 |
Why not click here or view trends?
log id: 2292844